Chimin Health Management Co., Ltd. (SHA:603222)

Market Cap	5.31B +78.0%
Revenue (ttm)	668.04M -7.6%
Net Income	-257.87M
EPS	-0.48
Shares Out	523.09M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,259,767
Average Volume	34,933,013
Open	10.45
Previous Close	10.42
Day's Range	10.08 - 10.48
52-Week Range	5.84 - 15.10
Beta	0.44
RSI	54.08
Earnings Date	Apr 30, 2026

About Chimin Health Management

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and o...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1996
• Employees: 1,994
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603222

Financial Performance

In 2025, Chimin Health Management's revenue was 685.96 million, a decrease of -11.57% compared to the previous year's 775.73 million. Losses were -245.58 million, 311.3% more than in 2024.